Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen

FEMS Immunology and Medical Microbiology

Volumn 29, Issue 4, 2000, Pages 247-253

  Andersson, Christin ^a   Liljeström, Peter ^b,c   Ståhl, Stefan ^a   Power, Ultan F ^d  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

DNA immunisation; Respiratory syncytial virus; Semliki Forest virus

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; PLASMID DNA; PLASMID VECTOR; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VACCINE BBG2NA; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LOWER RESPIRATORY TRACT INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEMLIKI FOREST ALPHAVIRUS; TREATMENT OUTCOME; VACCINE PRODUCTION; VIRUS GENE; VIRUS INFECTION;

EID: 0033671154     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00213-3     Document Type: Article

References (33)

1. Nucleic acid immunization: Concepts and techniques associated with third generation vaccines
2. DNA and RNA-based vaccines: Principles, progress and prospects
3. Production of recombinant subunit vaccines: Protein immunogens, live delivery systems and nucleic acid vaccines
4. Respiratory syncytial virus
5. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
6. Respiratory syncytial virus vaccines
7. Protection against respiratory syncytial virus infection by DNA immunization
8. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice
9. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate
10. Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus
11. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment
12. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2Na, in aluminum hydroxide
13. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na
14. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunised with a recombinant RSV G protein fragment
15. CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment
16. Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: Influence of adjuvants and maternal antibodies
17. Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na
18. The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein
19. Analysis and use of the serum albumin binding domains of streptococcal protein G
20. The serum albumin-binding region of streptococcal protein G: A bacterial fusion partner with carrier-related properties
21. Genetic optimization of recombinant glycoprotein production by mammalian cells
22. Alphavirus expression vectors and their use as recombinant vaccines: A minireview
23. Enhancing immune responses using suicidal DNA vaccines
24. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
25. pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts
26. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers
27. Truncated fragments in polymerase chain reaction-based DNA sequencing
28. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
29. An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein
30. Use of the Sindbis replicon system for expression of LaCrosse virus envelope proteins in mosquito cells
31. The Semliki Forest virus vector induces p53-independent apoptosis
32. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages